Completed PHASE3 INTERVENTIONAL NCT00311636

Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

Prevention of Chemotherapy-induced Menopause by Temporary Ovarian Suppression With Triptorelin Vs. Control in Young Breast Cancer Patients. A Randomized Phase III Multicenter Study [PROMISE]

Sponsor: Gruppo Italiano Mammella (GIM)

Conditions Breast Cancer

Interventions adjuvant therapy cyclophosphamide docetaxel doxorubicin hydrochloride epirubicin hydrochloride fluorouracil methotrexate paclitaxel triptorelin

Updated 5 times since 2017 Last updated: Jun 25, 2013 Started: Sep 30, 2003 Primary completion: Jan 31, 2008 Completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00311636, this PHASE3 trial focuses on Breast Cancer and remains completed. Sponsored by Gruppo Italiano Mammella (GIM), it has been updated 5 times since 2003, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gruppo Italiano Mammella (GIM)

Data source: National Cancer Institute (NCI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Castelfranco - TV, Italy , Como, Italy , Cuneo, Italy , Florence, Italy , Genoa, Italy , Livorno, Italy , Mantova, Italy , Naples, Italy , Perugia, Italy , Pisa, Italy and 6 more locations